Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

PET scan-directed chemoradiation for esophageal squamous cell carcinoma: no benefit for a change in chemotherapy in PET non-responders.

Greally M, Chou J, Molena D, Rusch VW, Bains MS, Park BJ, Wu AJ, Goodman KA, Kelsen DP, Janjigian YY, Ilson DH, Ku GY.

J Thorac Oncol. 2018 Oct 31. pii: S1556-0864(18)33385-9. doi: 10.1016/j.jtho.2018.10.152. [Epub ahead of print]

PMID:
30391577
2.

Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.

Nobel TB, Barbetta A, Hsu M, Tan KS, Pinchinat T, Schlottmann F, Bains MS, Ku GY, Wu AJ, Patti MG, Jones DR, Molena D.

J Gastrointest Surg. 2018 Sep 13. doi: 10.1007/s11605-018-3958-8. [Epub ahead of print]

PMID:
30215197
3.

Thoracic Scoliosis in Patients with Primary Spontaneous Pneumothorax.

Lee Y, Kim YJ, Ryu HY, Ku GW, Sung TY, Yoon YS, Kim TK.

Korean J Thorac Cardiovasc Surg. 2018 Aug;51(4):254-259. doi: 10.5090/kjtcs.2018.51.4.254. Epub 2018 Aug 5.

4.

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.

Mondaca S, Margolis M, Sanchez-Vega F, Jonsson P, Riches JC, Ku GY, Hechtman JF, Tuvy Y, Berger MF, Shah MA, Kelsen DP, Ilson DH, Yu K, Goldberg Z, Epstein AS, Desai A, Chung V, Chou JF, Capanu M, Solit DB, Schultz N, Janjigian YY.

Gastric Cancer. 2018 Aug 7. doi: 10.1007/s10120-018-0861-7. [Epub ahead of print]

PMID:
30088161
5.

A Genetic Interaction Map of Insulin Production Identifies Mfi as an Inhibitor of Mitochondrial Fission.

Lee J, Pappalardo Z, Chopra DG, Hennings TG, Vaughn I, Lan C, Choe JJ, Ang K, Chen S, Arkin M, McManus MT, German MS, Ku GM.

Endocrinology. 2018 Sep 1;159(9):3321-3330. doi: 10.1210/en.2018-00426.

PMID:
30059978
6.

In Vivo Deletion of β-Cell Drp1 Impairs Insulin Secretion Without Affecting Islet Oxygen Consumption.

Hennings TG, Chopra DG, DeLeon ER, VanDeusen HR, Sesaki H, Merrins MJ, Ku GM.

Endocrinology. 2018 Sep 1;159(9):3245-3256. doi: 10.1210/en.2018-00445.

PMID:
30052866
7.

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.

Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O'Reilly EM, Yu KH.

BMC Cancer. 2018 Jun 27;18(1):693. doi: 10.1186/s12885-018-4605-1.

8.

Spatial and Temporal Confined Photothermolysis of Cancer Cells Mediated by Hollow Gold Nanospheres Targeted to Epidermal Growth Factor Receptors.

Ku G, Huang Q, Wen X, Ye J, Piwnica-Worms D, Li C.

ACS Omega. 2018 May 31;3(5):5888-5895. doi: 10.1021/acsomega.8b00712.

9.

Unusual Pseudoaneurysm of the Dorsalis Pedis Artery after an Iatrogenic Injury.

Lee Y, Ryu HY, Kim YJ, Ku GW.

Korean J Thorac Cardiovasc Surg. 2018 Jun;51(3):213-215. doi: 10.5090/kjtcs.2018.51.3.213. Epub 2018 Jun 5.

10.

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.

Barbetta A, Hsu M, Tan KS, Stefanova D, Herman K, Adusumilli PS, Bains MS, Bott MJ, Isbell JM, Janjigian YY, Ku GY, Park BJ, Wu AJ, Jones DR, Molena D.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2710-2721.e3. doi: 10.1016/j.jtcvs.2018.01.086. Epub 2018 Feb 15.

PMID:
29548582
11.

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH.

JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013. Epub 2018 May 10.

12.

The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output.

Bulut-Karslioglu A, Macrae TA, Oses-Prieto JA, Covarrubias S, Percharde M, Ku G, Diaz A, McManus MT, Burlingame AL, Ramalho-Santos M.

Cell Stem Cell. 2018 Mar 1;22(3):369-383.e8. doi: 10.1016/j.stem.2018.02.004.

PMID:
29499153
13.

The Cultural Boundaries of Perspective-Taking: When and Why Perspective-Taking Reduces Stereotyping.

Wang CS, Lee M, Ku G, Leung AK.

Pers Soc Psychol Bull. 2018 Jun;44(6):928-943. doi: 10.1177/0146167218757453. Epub 2018 Feb 28.

PMID:
29486634
14.

Systemic therapy for esophagogastric cancer: immune checkpoint inhibition.

Lyons TG, Ku GY.

Chin Clin Oncol. 2017 Oct;6(5):53. doi: 10.21037/cco.2017.09.03.

15.

Systemic therapy for esophageal cancer: chemotherapy.

Ku GY.

Chin Clin Oncol. 2017 Oct;6(5):49. doi: 10.21037/cco.2017.07.06. Review.

16.

Systemic therapy for esophagogastric cancer: targeted therapies.

Lyons TG, Ku GY.

Chin Clin Oncol. 2017 Oct;6(5):48. doi: 10.21037/cco.2017.07.02. Review.

17.

Preface on Esophagus Cancer.

Ku GY, Ilson DH.

Chin Clin Oncol. 2017 Oct;6(5):44. doi: 10.21037/cco.2017.10.04. No abstract available.

18.

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

Janjigian YY, Sanchez-Vega F, Jonsson P, Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R, Bouvier N, Vakiani E, Gao J, Heins ZJ, Gross BE, Kelsen DP, Zhang L, Strong VE, Schattner M, Gerdes H, Coit DG, Bains M, Stadler ZK, Rusch VW, Jones DR, Molena D, Shia J, Robson ME, Capanu M, Middha S, Zehir A, Hyman DM, Scaltriti M, Ladanyi M, Rosen N, Ilson DH, Berger MF, Tang L, Taylor BS, Solit DB, Schultz N.

Cancer Discov. 2018 Jan;8(1):49-58. doi: 10.1158/2159-8290.CD-17-0787. Epub 2017 Nov 9.

PMID:
29122777
19.

The effect of text message support on diabetes self-management in developing countries - A randomised trial.

Van Olmen J, Kegels G, Korachais C, de Man J, Van Acker K, Kalobu JC, van Pelt M, Ku GM, Hen H, Kanda D, Malombo B, Darras C, Schellevis F.

J Clin Transl Endocrinol. 2017 Jan 3;7:33-41. doi: 10.1016/j.jcte.2016.12.005. eCollection 2017 Mar.

20.

Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis.

Ridouane Y, Lopes G, Ku G, Masud H, Haaland B.

Oncotarget. 2017 Aug 11;8(39):66458-66466. doi: 10.18632/oncotarget.20185. eCollection 2017 Sep 12.

21.

Laser streaming: Turning a laser beam into a flow of liquid.

Wang Y, Zhang Q, Zhu Z, Lin F, Deng J, Ku G, Dong S, Song S, Alam MK, Liu D, Wang Z, Bao J.

Sci Adv. 2017 Sep 27;3(9):e1700555. doi: 10.1126/sciadv.1700555. eCollection 2017 Sep.

22.

Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.

Vellayappan BA, Soon YY, Ku GY, Leong CN, Lu JJ, Tey JC.

Cochrane Database Syst Rev. 2017 Aug 22;8:CD010511. doi: 10.1002/14651858.CD010511.pub2. Review.

PMID:
28829911
23.

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma.

Ku G, Ilson D.

Lancet Oncol. 2017 May;18(5):e243. doi: 10.1016/S1470-2045(17)30280-2. No abstract available.

PMID:
28495288
24.

The Current Status of Immunotherapies in Esophagogastric Cancer.

Ku GY.

Surg Oncol Clin N Am. 2017 Apr;26(2):277-292. doi: 10.1016/j.soc.2016.10.012. Review.

PMID:
28279469
25.

Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.

Ku GY.

Surg Oncol Clin N Am. 2017 Apr;26(2):241-256. doi: 10.1016/j.soc.2016.10.009. Epub 2017 Feb 9. Review.

PMID:
28279467
26.

A Whole-Genome RNA Interference Screen Reveals a Role for Spry2 in Insulin Transcription and the Unfolded Protein Response.

Pappalardo Z, Gambhir Chopra D, Hennings TG, Richards H, Choe J, Yang K, Baeyens L, Ang K, Chen S, Arkin M, German MS, McManus MT, Ku GM.

Diabetes. 2017 Jun;66(6):1703-1712. doi: 10.2337/db16-0962. Epub 2017 Feb 28.

27.

Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma.

Ku GY, Bains MS, Park DJ, Janjigian YY, Rusch VW, Rizk NP, Yoon SS, Millang B, Capanu M, Goodman KA, Ilson DH.

J Gastrointest Oncol. 2016 Dec;7(6):828-837. doi: 10.21037/jgo.2016.08.09.

28.

64 CuS-labeled nanoparticles: a new sentinel-lymph-node-mapping agent for PET-CT and photoacoustic tomography.

Liu Q, Zhou M, Li P, Ku G, Huang G, Li C, Song S.

Contrast Media Mol Imaging. 2016 Nov;11(6):475-481. doi: 10.1002/cmmi.1709. Epub 2016 Aug 15.

PMID:
27523742
29.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jun;14(6):715-24.

30.

Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.

Ku GY, Kriplani A, Janjigian YY, Kelsen DP, Rusch VW, Bains M, Chou J, Capanu M, Wu AJ, Goodman KA, Ilson DH.

Cancer. 2016 Jul 1;122(13):2083-90. doi: 10.1002/cncr.30028. Epub 2016 May 6.

31.

Traumatic intrapericardial diaphragmatic hernia: findings on a computed tomography scan.

Choi MS, Ku GW, Park SS, Choi SY, Choi JH.

ANZ J Surg. 2018 May;88(5):E473-E474. doi: 10.1111/ans.13430. Epub 2015 Dec 23. No abstract available.

PMID:
26695101
32.

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma.

Chhabra A, Ong LT, Kuk D, Ku G, Ilson D, Janjigian YY, Wu A, Schöder H, Goodman KA.

Br J Cancer. 2015 Dec 22;113(12):1658-65. doi: 10.1038/bjc.2015.416. Epub 2015 Dec 10.

33.

Process evaluation of a mobile health intervention for people with diabetes in low income countries - the implementation of the TEXT4DSM study.

Van Olmen J, Van Pelt M, Malombo B, Ku GM, Kanda D, Heang H, Darras C, Kegels G, Schellevis F.

J Telemed Telecare. 2017 Jan;23(1):96-105. doi: 10.1177/1357633X15617885. Epub 2016 Jul 8.

PMID:
26656894
34.

Spanning the canyon between stem cell transplantation and palliative care.

Roeland E, Ku G.

Hematology Am Soc Hematol Educ Program. 2015;2015:484-9. doi: 10.1182/asheducation-2015.1.484.

PMID:
26637762
35.

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen YB, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M.

Bone Marrow Transplant. 2016 Jan;51(1):58-66. doi: 10.1038/bmt.2015.223. Epub 2015 Oct 5.

36.

Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield.

Afaneh C, Levy A, Selby L, Ku G, Tang L, Yoon SS, Coit D, Strong VE.

J Gastrointest Surg. 2016 Jan;20(1):165-71; discussion 171. doi: 10.1007/s11605-015-2948-3. Epub 2015 Sep 24.

37.

Long-Term Survival With Salvage Surgery for Recurrent Esophageal Adenocarcinoma After Chemoradiotherapy.

Ku GY, Ilson DH.

J Clin Oncol. 2015 Nov 20;33(33):3854-7. doi: 10.1200/JCO.2015.62.6796. Epub 2015 Aug 31. No abstract available.

PMID:
26324375
38.

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.

Janjigian YY, Vakiani E, Ku GY, Herrera JM, Tang LH, Bouvier N, Viale A, Socci ND, Capanu M, Berger M, Ilson DH.

PLoS One. 2015 Aug 14;10(8):e0134731. doi: 10.1371/journal.pone.0134731. eCollection 2015.

39.

Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.

Park DJ, Seo AN, Yoon C, Ku GY, Coit DG, Strong VE, Suh YS, Lee HS, Yang HK, Kim HH, Yoon SS.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1508-15. doi: 10.1245/s10434-015-4790-y. Epub 2015 Aug 11.

40.

Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.

Klyuchnikov E, Bacher U, Kröger NM, Hari PN, Ahn KW, Carreras J, Bachanova V, Bashey A, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Hertzberg MS, Holmberg LA, Kharfan-Dabaja MA, Klein A, Ku GH, Laport GG, Lazarus HM, Miller AM, Mussetti A, Olsson RF, Slavin S, Usmani SZ, Vij R, Wood WA, Maloney DG, Sureda AM, Smith SM, Hamadani M.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2091-2099. doi: 10.1016/j.bbmt.2015.07.028. Epub 2015 Aug 4.

41.

Adapting chronic care models for diabetes care delivery in low-and-middle-income countries: A review.

Ku GM, Kegels G.

World J Diabetes. 2015 May 15;6(4):566-75. doi: 10.4239/wjd.v6.i4.566. Review.

42.

Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansion.

Berger M, Scheel DW, Macias H, Miyatsuka T, Kim H, Hoang P, Ku GM, Honig G, Liou A, Tang Y, Regard JB, Sharifnia P, Yu L, Wang J, Coughlin SR, Conklin BR, Deneris ES, Tecott LH, German MS.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2888-93. doi: 10.1073/pnas.1319378112. Epub 2015 Feb 18.

45.

Emerging mAbs for the treatment of esophagogastric cancer.

Ku GY, Ilson DH.

Expert Opin Emerg Drugs. 2015 Mar;20(1):63-74. doi: 10.1517/14728214.2015.983072. Epub 2014 Dec 6. Review.

PMID:
25483267
46.

Theranostic probe for simultaneous in vivo photoacoustic imaging and confined photothermolysis by pulsed laser at 1064 nm in 4T1 breast cancer model.

Zhou M, Ku G, Pageon L, Li C.

Nanoscale. 2014 Dec 21;6(24):15228-35. doi: 10.1039/c4nr05386a. Epub 2014 Nov 7.

47.

Survivorship: screening for cancer and treatment effects, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Nov;12(11):1526-31.

49.

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1396-406.

50.

Management of gastric cancer.

Ku GY, Ilson DH.

Curr Opin Gastroenterol. 2014 Nov;30(6):596-602. doi: 10.1097/MOG.0000000000000115. Review.

PMID:
25197781

Supplemental Content

Support Center